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A B S T R A C T
 
Background: In July 2004, the Brazilian Ministry of Health through the National Health 
Surveillance Agency made the fortification of wheat flour and cornmeal (maize flour) with 
iron and folic acid mandatory, with the intention of reducing the rate of diseases such as 
neural tube defects.
Objective: The aim of the study was to investigate the impact of the folic acid fortified wheat 
flour and cornmeal on serum and red blood cell folate levels and on the reduction of neural 
tube defects in different Brazilian studies.
Methods: In order to compare folate concentrations in the Brazilian population prior to and 
following the implementation of mandatory fortification of wheat and cornmeal, studies 
that involved blood draws between January 1997 and May 2004 (pre-fortification period), 
and from June 2004 to the present (post-fortification period) were chosen. The data search 
included PubMed and Scopus databases as well as the Brazilian Digital Library of Theses 
and Dissertations. The following keywords were employed for the query: folate, folic acid, 
fortification, Brazil, healthy population, the elderly, children and pregnant women.
Results: A total of 47 Brazilian studies were selected; 26 from the pre-fortification period 
and 22 after the fortification implementation. The studies were classified according to 
the cohort investigated (pregnant women, children, adolescents, adults and the elderly). 
After the implementation of flour fortification with folic acid in Brazil, serum folate 
concentrations increased in healthy populations (57% in children and adolescents and 
174% in adults), and the incidence of neural tube defects dropped.
Conclusion: Folic acid fortification of wheat flour and cornmeal increased the blood folate 
concentrations and reduced the incidence of neural tube defects.
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Introduction
Folic acid (FA) is a hydrosoluble vitamin essential for human 
health; its main roles in cell metabolism involve DNA synthesis 
and supplying methyl groups for homocysteine (Hcy), DNA, 
protein and lipid methylation reactions.1
The term folate is used to designate the polyglutamate 
form of water-soluble B vitamin present in edibles, while the 
term folic acid corresponds to the monoglutamate form used 
in supplements and in the fortification of food.2 Folate rich 
foods include: green vegetables (broccolis, lettuce, spinach 
and asparagus), beans, fruit (lemons, bananas and melons), 
dry cereals, whole-grains, liver, kidney and mushrooms.3 
The physiological folate requirements increase when there 
is a corresponding increase in cell division such as during 
pregnancy, lactation and in early childhood; or whenever 
individuals are afflicted with certain diseases, such as 
hemolytic anemia, leukemia and other malignant diseases, as 
well as in alcoholism.4
It is believed to be difficult to obtain the required intake 
of this vitamin by means of a balanced diet alone (without 
fortified foods) when there is an increase in physiological 
necessities. A normal diet supplies around 0.25 mg of folate/
day, considering a diet of 2200 calories per day. The difficulty 
in fulfilling the requirements may be explained by the low 
bioavailability of folate in foods and the low dietary intake of 
foods that are natural sources of this vitamin. Furthermore, 
high temperature processing of foods results in considerable 
loss of folate, reducing its content by 50%.5 
The recommended dietary allowance (RDA), estimated 
average requirement (EAR) and the tolerable upper intake 
level (UL) reference values for folate differ according to age 
(children, adolescents and adults) remembering that intake 
requirements are higher for pregnant (RDA 600 μg/day and EAR 
520 μg/day) and breast-feeding women (RDA 500 μg/day and 
EAR 450 μg/day).6 During pregnancy, cells multiply intensively 
due to the widening of the uterus, placental development, 
increase in blood volume and fetal development, which 
increases folate and B12 vitamin necessities accordingly.7 
Adequate intake of these vitamins is essential, since folate 
insufficiency has been identified as a risk factor for congenital 
disorders especially neural tube defects (NTDs). They result 
from neural tube closing failure during the early development 
of the embryo, typically between the 21st and 28th day after 
conception, most frequently resulting in anencephaly and 
spina bifida.
Since pregnancy is not always planned, it is important 
that women of child-bearing age have access to a suitable 
quantity of FA, at least one month prior to becoming pregnant. 
Accordingly, it is recommended that women of child-
bearing age consume 400 μg of FA daily,  via fortified foods, 
supplements or both, in addition to  the quantity they acquire 
from their normal daily diet.6 Considering the difficulties 
to obtain the folate requirements from a normal balanced 
diet, several countries decided to implement mandatory FA 
fortification of foods, starting with the United States in 1998, 
followed shortly by Canada, Chile and several others.
In Brazil, the Ministry of Health through the National 
Health Surveillance Agency (ANVISA) made the iron and 
FA fortification of wheat and cornmeal mandatory in July 
2004, with the intention of reducing the rate of pathologies, 
like NTDs, nationally. When the RDC Resolution no. 344 was 
issued on December 13, 2002, ANVISA dictated that all wheat 
flour and cornmeal, whether sold directly to consumers or 
to the food industry for the manufacture of edibles, must be 
enriched with iron and FA. It was established that every 100 
g of wheat flour and cornmeal must contain at least 4.2 mg 
of iron and 150 μg of FA.8 However, no nationwide studies 
have been carried out to evaluate the concentrations of folate 
consumed by the Brazilian population prior to and following 
the mandatory implementation of fortified wheat flour 
and cornmeal. Accordingly, the purpose of this review is to 
investigate the impact of the FA fortification of wheat flour 
and cornmeal on serum and red blood cell folate levels, and 
to evaluate the reduction of NTDs in different strata of the 
Brazilian population.
Methods
In order to compare folate concentrations in the Brazilian 
population prior to and following the implementation of 
mandatory fortification of wheat flour and cornmeal, studies 
that involved blood draws between January 1997 and May 
2004 (the pre-fortification period), and from June 2004 to 
the present (the post-fortification period) were chosen. Data 
reviewed included PubMed and Scopus databases as well 
as the Brazilian Digital Library of Theses and Dissertations. 
The following keywords were employed in the query: folate, 
folic acid, fortification, Brazil, healthy population, the elderly, 
children and pregnant women.
Studies in which the sample collection included both time 
periods were classified as “pre-fortification studies”, as long 
as the sample collection period prior to June 2004 was longer 
than the period after June 2004. Likewise, studies in which the 
collection period after June 2004 was greater than the period 
prior to mandatory fortification were classified as “post-
fortification studies”. A number of studies did not specify the 
sample collection period; in these cases, emails were sent to 
the respective corresponding authors in order to determine 
this information.
Transversal and/or prospective studies were selected, 
without interventions, carried out on different cohorts of the 
Brazilian population, such as pregnant women, neonates, 
children and adolescents, adults and the elderly. The studies 
that evaluated the concentrations of folate in unhealthy 
populations were also selected and the data are presented 
in the Tables below but were not taken into consideration in 
the whole evaluation between the pre- and post-fortification 
periods. For consistency purposes , studies that presented 
folate concentrations expressed in ng/mL had their values 
converted into nmol/L using a conversion factor of 2.2669 for 
this review.
In order to evaluate the concentrations of serum folate 
between the pre- and post-fortification periods, the increase 
of serum concentrations was estimated in children and 
adolescents and adults. Pregnant women were not considered 
for this evaluation, because the studies found presented great 
variations in the gestational age of the subjects within this 
cohort. Neonates and the elderly were not evaluated either, 
because few studies involving these cohorts were found for 
the two periods considered.
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Results
A total of 47 Brazilian studies were selected, including 26 
from the pre-fortification and 22 from the post-fortification 
periods. The studies were classified according to the cohort 
investigated (pregnant women, children, adolescents, adults 
and the elderly). Several articles analyzed more than one type 
of population in the same study and so that these studies may 
appear in more than one Table in the results section.
Tables 1 to 7 present the characteristics of the selected 
studies, including where they were carried out, the period 
of the sample collection, the characteristics of the evaluated 
cohort, the number of individuals involved in the study (n) 
and the method used for quantifying the folate.
Tables 1 to 3 present the characteristics of the studies that 
evaluated the concentrations of serum folate on different 
healthy populations, while Tables 4 and 5 present the 
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Pregnant women Pregnant women
Thame. 
Guerra-
Shinohara et 
al. 200210
February 
to October 
1997
São Paulo 
- SP
Pregnant 
women 
with NTD 
babies 
(30.6 ± 5.5 
weeks)
38 19.6 (± 
8.7)a
Ionic capture  
(IMx System®. 
ABBOTT)
Guerra-
Shinohara. 
Pereira et al. 
201013
February 
2004 to 
December 
2005
São 
Paulo 
- SP
Pregnant 
women  
(12 weeks)
88 27.4 (19.6; 
39.3)d
CL 
(Immulite®. 
DPC Med Lab)
Guerra-
Shinohara. 
Paiva et al. 
200211
August to 
November 
1999
Jundiaí 
- SP
Women in 
labor 
(38 to 42 
weeks)
69 13.9 (± 
5.6)a
Ionic capture  
(IMx System®. 
ABBOTT)
Kubota. 
201014
February 
2004 to 
December 
2005
São 
Paulo 
- SP
Pregnant 
women 
(8 to 12 
weeks)
16 weeks
 
 
 
28 weeks
 
 
36 weeks
38 
 
 
 
50 
 
 
 
50 
 
 
50
24.4 (± 
13.6)a 
23.8 (13.5 – 
28.4)d
24.3 (± 
17.5)a
22.1 (15.7 – 
29.2)d
22.3 (± 9.9)a
20.9 (15.0 – 
29.7)d
21.4 (± 7.7)a
20.6 (15.5 – 
25.6)d
CL 
(Immulite®. 
DPC Med Lab)
Guerra-
Shinohara. 
Morita et al. 
20047
2001 Sorocaba 
- SP
Women in 
labor  
(38 to 42 
weeks)
112 12.9  
(12.0 - 
14.0)b
Ionic capture  
(IMx System®. 
ABBOTT)
Barbosa. 
Stabler. 
Machado et 
al. 200812
April 2001 
to May 
2003
Sorocaba 
- SP
Women in 
labor  
(38 to 42 
weeks)
275 12.5c  
13.7 (± 
6.8)a
Ionic capture  
(IMx System®) 
and CL 
(Immulite®)
Neonates Neonates
Guerra-
Shinohara. 
Paiva et al. 
200211
August to 
November 
1999
Jundiaí 
- SP
Blood 
sample 
from 
umbilical 
cord
69 27.9 (± 
3.9)a
Ionic capture 
(IMx System®. 
ABBOTT)
Guerra-
Shinohara. 
Morita et al. 
20047
2001 Sorocaba 
- SP
Blood 
sample 
from 
placental 
neonatal 
vein
112 30.9 
(29.8 - 
32.1)b
Ionic capture 
(IMx System®. 
ABBOTT)
Couto. 
Moreira et al. 
200715
February to 
December 
2000
Salvador 
- BA
Neonates 143 17.7 (± 
8.0)a
ECL 
immunoassay 
(ECLIA, Roche)
CL: chemiluminescence; ECL: electrochemiluminescence; NTD: neural tube defects. 
a Serum folate concentration: mean (± SD).  
b Serum folate concentration: geometric means (95% CI).  
c Serum folate concentration: median. 
d Serum folate concentration: median (P25-P75).
Table 1 - Serum folate concentrations in healthy pregnant women and neonates.
278 rev bras hematol hemoter. 2 0 1 4;36(4):275–286
(13%), 1 (2%), 2 (4%) and 6 (13%) studies were conducted in the 
southern, mid-west, northern and northeastern geographical 
regions, respectively.
Discussion
The need to reduce the incidence of congenital disorders in 
the population has led some countries to adopt a program to 
fortify foods with FA. Other countries, especially in Europe, 
have implemented special women’s healthcare initiatives, 
characteristics of the studies involving unhealthy populations. 
Tables 6 and 7 present the characteristics of the studies that 
evaluate the total blood or red blood cell folate concentrations 
among healthy and unhealthy populations, respectively.
Increases of 57% and 174% of the serum folate concentration 
were observed between the pre- and post-fortification periods 
for the children and adolescents cohort and for the healthy 
adults cohort, respectively.
Of the total number of studies encountered, 32 (68%) were 
held at  southeastern geographical region of Brazil, while 6 
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Children and adolescents Children and adolescents
Félix, Leistner 
et al., 200416
2000 to 2001 Porto 
Alegre - SP
Children 
without NTD
44 12.8 (± 
9.4)a
Ionic 
capture 
(IMx 
System®. 
ABBOTT)
Hadler,  
Sigulem et al., 
200820
2005 Goiânia -  
GO
Children (6 to 
24 months)
157 29.5 (± 12.2)a CL (Bayer)
Do Prado, 
D’almeida et 
al., 200617
November 
2002 to 
September 
2003
São Paulo 
- SP
Healthy 
children and 
adolescents 
(29 girls)
32 14.3 (± 
5.4)a
Ionic 
capture 
(IMx 
System®. 
ABBOTT)
Steluti,  
Martini et al., 
201121
2006 Indaia-tuba 
- SP
Adolescents:
- Girls
- Boys
36
53
21.5 (± 9.3)a
20.4 (± 6.6)a
ECL (Elecsys®)
Galdieri, 
Arrieta et al., 
200718
2002 to 2004 São Paulo 
- SP
Healthy 
children
30 18.8 (± 
6.8)a
HPLC Cardoso,  
Scopel et al., 
201222
December 
2007
Acrelân-dia 
- AC
Children (6 
months to 10 
years old)
1032 23.3 (17.7; 
30.3)d
FIA
Gonçalves, 
D’almeida et 
al., 200719
November 
2002 to 
September 
2003
São Paulo 
- SP
Healthy girls 
(children and 
adolescents)
52 15.1 (± 
5.1)a
Ionic 
capture 
(IMx 
System®. 
ABBOTT)
Fialho, 201223 2008 Fortaleza -  
CE
Children  
and 
adolescents H. 
pylori (-)
47 30.4 (± 8.4)a CL 
(Immulite®, 
DPC Med Lab)
Bigio 201124 2008 to  
2010
São Paulo -  
SP
Adolescents:
- Girls
- Boys
82
101
 
19.3 (± 6.6)a
18.6 (± 6.6)a
ECL (Elecsys®)
Da Costa, 
Schtscherbyna 
et al., 201325
2005 to  
2006
Rio de 
Janeiro - RJ
Girls
- 11 to 14 
years old
- 15 to 19 
years old
25
18
24.7c
27.9c
RIA 
(Dualcount, 
DPC® Medlab)
Elderly Elderly
Moriguti, 
Ferriolli et al.,
199926
1998 Ribeirão 
Preto - SP
Elderly (men) 8 15.9 (± 
2.5)a
? Tassino,  
Campos et al., 
200927
2006 to  
2007
Natal - RN Low income 
elderly
205 26.3 (± 10.2)a CL (Immulite®, 
DPC Med Lab)
Xavier, Costa  
et al., 201028
November 
2006 to 
September 
2007
Campinas - 
SP
Elderly 250 24.7 (± 6.9)a ECL (Elecsys®)
Coussirat, 201029 July 2005 to 
June 2010
Porto 
Alegre - RS
Elderly 420 28.6 (± 11.3)a CL (VITROS 
ECi Immuno-
diagnostic 
System -J&J)
NTD: neural tube defects; CL: chemiluminescence; ECL: electrochemiluminescence; HPLC: high-performance liquid chromatography; FIA: fluoroimmunoassay. 
a Serum folate concentration: mean (± SD). 
b Serum folate concentration: geometric means (95% CI).  
c Serum folate concentration:  median. 
d Serum folate concentration:  median (P25-P75). 
Missing information was represented with a question mark (?).
Table 2 - Serum folate concentrations in healthy pregnant women and neonates.
ia
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Adults Adults
Martins, 
D’Almeida et 
al., 200330
? São Paulo - 
SP
Day time 
working 
men
Shift 
working 
men
22
30
19.2 (± 
8.9)a
11.5 (± 
5.1)a
CL (ACS :180®) Mendes, Biselli 
et al., 201040
February 
2005 to 
February 
2008
São José do 
Rio Preto -  
SP
Mothers 
of healthy 
children, 
polymor-
phism 
DHFR ins/
ins 19bp 
intron 1
ins/ins
ins/del
del/del
42
85
57
35.3c
32.0c
33.1c
CL (Immulite®, 
DPC Med Lab)
Félix, Leistner 
et al., 200416
2000 to  
2001
Porto 
Alegre - RS
Mothers 
of healthy 
children
44 8.8 (± 4.0)a Ionic capture 
(IMx System®. 
ABBOTT)
Xavier, Costa et 
al., 201028
November 
2006 to 
September 
2007
Campinas - 
SP
Adults 250 23.8 (± 9.2)a ECL (Elecsys®)
Pereira, 
Schettert et al., 
200431
2000 São Paulo -  
SP
Adults 209 12.1 (± 
4.3)a
Ionic capture 
(IMx System®. 
ABBOTT)
Barnabé, 201041 ? Campinas - 
SP
Adults 28 23.3 (± 6.9)a ECL (Elecsys®)
Tavares, 
Vieira-Filho et 
al., 200432
July 1998 Marabá –  
PA
Parkatêjê 
Índians
Women
Men
34
56
9.3 (± 2.9)a
7.0 (± 2.7)a
CL (Immulite®, 
DPC Med Lab)
Minozzo, 
Deimling et al., 
201042
July 2005 to 
July 2006
Porto 
Alegre - RS
Healthy 
men
53 14.4 (± 5.7)a CL (Access 
Immunoassay 
System 
Beckman 
Instruments)
Helfenstein, 
Fonseca et al., 
200533
2003 to 2004 São Paulo 
- SP
Healthy 
adults
56 13.6 (± 
0.9)e
AxSYM 
Analyzer
Braga, 
Vannucchi et al., 
201143
August 
2008 to 
November 
2009
Ribeirão 
Preto - SP
Healthy 
adults
9 32.6 (± 
11.8)a
CL (Immulite®, 
DPC Med Lab)
Muniz, 
Siqueira et al., 
200634
1999 to 2001 Recife - PE Healthy 
adults
108 17.5 (± 
7.0)a
CL (ACS :180®) Vinha, Jordão et 
al., 201144
2007 to 2008 Ribeirão 
Preto - SP
Adults 
undergoing 
surgery 
of burn 
sequelae1
8 17.0c CL (Immulite®, 
DPC Med Lab)
Faria-Neto, 
Chagas et al., 
200635
1999 to 2000 São Paulo -  
SP
Adults 
with 
normal 
or almost 
normal 
arteries
88 17.4 (± 
8.2)a
RIA (Dualcount, 
DPC® Medlab)
Chiarani, 201245 ? Porto 
Alegre - RS
Healthy 
adults
30 23.5 (± 2.2)a CL
Galdieri, 
Arrieta et al., 
200718
2002 to 2004 São Paulo -  
SP
Mothers 
of healthy 
children
25 13.0 (3.1)a HPLC Giusti, 201246 November 
2008 to 
September 
2011
São Paulo 
- SP
Women  
with no 
history of 
miscarriage
264 31.8 (± 1.5)a Microbiological 
assay
Almeida, 
Tomita et al., 
200836
March 2003 
to May 
2005
São Paulo -  
SP
Low 
income 
women
1085 14.3 (10.2 – 
20.9)d
Immunoassay 
(PerkinElmer®)
De Carvalho, 
Muniz et al., 
201347
2005 to  
2008
Recife - PE Healthy 
adults
51 34.3 (± 6.8)a ECL (Elecsys®)
Barbosa, 
Stabler, 
Trentin et al., 
200837
2003 Sorocaba -  
SP
Healthy 
women
102 15.2 (14.1-
16.4)b
16.3 (± 
6.0)a
CL (Immulite®, 
DPC Med Lab)
Biselli, 
Guerzoni et 
al., 201038
2001 and 
2004
São José do 
Rio Preto -  
SP
Adults 
polymor-
phism
MTHFR 
A1298C
AA
AC
CC
54
49
5
10.9 (± 5.0)a
10.7 (± 6.6)a
19.0 (± 4.5)a
CL (Immulite®, 
DPC Med Lab)
Blume, Boni 
et al., 201239
2000 to 
2005
Porto 
Alegre - RS
Obese 
adults 
(136 
women 
and 34 
men)
170 18.4 (11.1 – 
26.3)d
CL (Centaur®)
NTD: neural tube defects; MTHFR: methylenetetrahydrofolate reductase; DHFR: dihydrofolate reductase; CL: chemiluminescence; ECL: electrochemiluminescence.2  
a Serum folate concentration: mean (± SD). 
b Serum folate concentration: geometric means (95% CI). 
c Serum folate concentration:  median. 
d Serum folate concentration:  median (P25-P75). 
e Serum folate concentration: mean (± SEM). 
The burns occurred at least one year before the study. Missing information is represented with a question mark (?).
Table 3 - Serum folate concentrations in healthy adults.
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NTD and abortion NTD and abortion
Thame, 
Guerra-
Shinohara et 
al., 200210
February 
to October 
1997
São Paulo - 
SP
Pregnant 
women 
carrying 
fetuses with 
NTD
17 12.6 (± 4.4)a 
11.3c
Ionic 
capture  
(IMx 
System®. 
ABBOTT)
Guerra-
Shinohara, 
Pereira et al., 
201013
February 
2004 to 
December 
2005
São Paulo -  
SP
Women 
who had 
spontaneous 
abortion
12 26.3 (20.9; 
40.7)d
CL (Immulite®, 
DPC Med Lab)
Félix, Leistner 
et al., 200416
2000 to 2001 Porto 
Alegre - RS
Mothers of 
children with 
NTD 
Children with 
NTD
41
41
16.7 (± 
10.2)a
25.8 (± 
15.2)a
Ionic 
capture  
(IMx 
System®. 
ABBOTT)
Giusti, 201246 November 
2008 to 
September 
2011
São Paulo 
- SP
Women with: 
Primary 
abortion 
Secondary 
abortion
117
139
32.3 (31.1 – 
33.4)a
34.2 (33.2 – 
35.2)a
Microbiological 
assay
Cunha, 
Hirata et al., 
200248
? São Paulo 
- SP
Children 
with NTD, 
polymorphism 
MTHFR C677T
CC
 
CT/TT
 
 
 
 
12
 
13
 
 
 
 
24.0 (± 
8.0)a 
30.0 (± 
7.0)a
Ionic 
capture  
(IMx 
System®. 
ABBOTT)
Cardiometabolic alterations Cardiometabolic alterations
Helfenstein, 
Fonseca et al., 
200533
2003 to 2004 São Paulo 
- SP
Adults with:
- DM2 and MI
- DM2
- MI
43
50
47
20.8 (± 1.6)e
21.1 (± 1.6)e
14.0 (± 0.9)e
AxSYM 
Analyzer, 
ABBOTT
Scorsatto, 
Uehara et al., 
201151
2008 to 2009 Rio de 
Janeiro - RJ
Women with 
MS
55 12.1 (± 3.8)a CL (Immulite®, 
DPC Med Lab)
Muniz, 
Siqueira et al., 
200634
1999 to 2001 Recife - PE Adults with 
CAD
93 14.4 (± 6.6)a CL (ACS 
:180®)
Galdieri, 
Arrieta et al., 
200718
2002 to 2004 São Paulo Children with 
congenital 
heart defects
Mothers of 
children with 
congenital 
heart defects
47
44
26.8 (± 
24.3)a
20.0 (± 
10.7)a
HPLC
Faria-Neto, 
Chagas et al., 
200635
1999 to 2000 São Paulo 
- SP
Adults with 
CAD
148 16.8 (± 7.5)a RIA 
(Dualcount, 
DPC® 
Medlab)
Melo, Persuhn 
et al., 200649
2003 Balneário 
Camboriu 
- SC
Adults 
with DM2, 
polymorphism 
MTHFR 
G1793A
GG
GA/AA
78
5
15.8c
8.0c
RIA 
(Dualcount, 
DPC® 
Medlab)
Uehara e 
Rosa, 200850
2002 to 2003 Rio de 
Janeiro - RJ
Adults with 
MS:
- Men
- Women
24
39
 
13.4 (± 7.9)e
14.5 (± 8.2)e
RIA 
(Dualcount, 
DPC® 
Medlab)
Scorsatto, 
Uehara et al., 
201151
2002 to 2003 Rio de 
Janeiro - RJ
Women with 
MS
38 15.7 (± 
10.7)a
CL 
(Immulite®, 
DPC Med 
Lab)
Biselli, 
Guerzoni et 
al., 201038
2001 to 2004 São José do 
Rio Preto 
- SP
Adults 
with CAD 
polymorphism 
MTHFR 
A1298C
AA
AC
CC
101
67
7
11.1 (± 6.8)a
13.1 (± 6.6)a
12.0 (± 1.8)a
CL 
(Immulite®, 
DPC Med 
Lab)
NTD: neural tube defects; DM2: type 2 diabetes mellitus; MI: myocardial infarction; MS: metabolic syndrome; CAD: coronary artery disease; MTHFR: 
methylenetetrahydrofolate reductase; CL: chemiluminescence; HPLC: high-performance liquid chromatography; RIA: radioisotope assay. 
a Serum folate concentration: mean (± SD). 
b Serum folate concentration: geometric means (95% CI). 
c Serum folate concentration: median. 
d Serum folate concentration: median (P25-P75). 
e Serum folate concentration: mean (± SEM). 
The missing information was represented with question mark (?).
Table 4 - Serum folate concentrations in unhealthy populations.
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tration 
(nmol/L)
 
 
 
 
Methods
Other conditions Other conditions
Do Prado, 
D’almeida et 
al., 200617
November 
2002 to 
September 
2003
São Paulo –  
SP
Children 
and 
adolescents 
with SLE (29 
girls)
32 16.1 (± 8.0)a Ionic capture 
(IMx System®. 
ABBOTT)
Chiarello, 
Penaforte et al., 
200953
2005 to  
2006
Ribeirão 
Preto - SP
Adults with 
Crohn’s 
disease
10 29.9 (± 7.9)a CL (Immulite®, 
DPC Med Lab)
Gonçalves, 
D’almeida et 
al., 200719
November 
2002 to 
September 
2003
São Paulo -  
SP
Girls 
(children 
and 
adolescents) 
with JIA
51 25.5 (± 
10.7)a
Ionic capture 
(IMx System®. 
ABBOTT)
Mendes, Biselli 
et al., 201040
February 
2005 to 
February 
2008
São José do 
Rio Preto 
- SP
Mothers 
of children 
with Down’s 
syndrome, 
polymorphism 
DHFR ins/ins 
19bp intron 1
ins/ins
ins/del
del/del
27
51
27
32.0c
26.9c
27.9c
CL (Immulite®, 
DPC Med Lab)
Vianna, 
Mocelin et al., 
200752
April 2003 to 
March 2005
Londrina -  
PR
Adults with 
end-stage 
kidney 
disease
93 9.3 (± 2.6)a ? Minozzo, 
Deimling et al., 
201042
July 2005 to 
July 2006
Porto 
Alegre -  
RS
Men exposed 
to lead
53 14.0 (± 5.0)a CL (Access 
Immunoassay 
System Beckman 
Instruments)
Fialho, 201223 2008 Fortaleza -  
CE
Children and 
adolescents H. 
pylori (+)
88 33.8 (± 8.6)a CL (Immulite®, 
DPC Med Lab)
Chiarani, 201245 ? Porto 
Alegre -  
RS
Adults with 
bipolar 
disorder
30 24.5 (± 2.5)a CL
Santos, 
Scazufca et al., 
201354
August 2005 
to April 2008
São Paulo 
- SP
Elderly with 
anemia
57 28.6 (± 13.8)a CL
De Carvalho, 
Muniz et al., 
201347
2005 to 2008 Recife -  
PE
Adults with 
NAFLD
35 34.6 (± 7.4)a ECL (Elecsys®)
Da Costa, 
Schtscherbyna 
et al., 201325
2005 to 2006 Rio de 
Janeiro -  
RJ
Girls with 
disordered 
eating
11 to 14 years-
old
15 to 19 years-
old
18
16
24.9c
28.3c
RIA (Dualcount, 
DPC® Medlab)
HIV: human immunodeficiency virus; SLE: systemic lupus erythematosus; JIA: juvenile idiopathic arthritis; DHFR: dihydrofolate reductase;  
NAFLD: non-alcoholic fatty liver disease; CL: chemiluminescence; ECL: electrochemiluminescence; RIA: radioisotope assay. 
a Serum folate concentration: mean (± SD).  
b Serum folate concentration: geometric means (95% CI). 
c Serum folate concentration: median.  
d Serum folate concentration: median (P25-P75). 
The missing information was represented as a question mark (?).
Table 5 - Serum folate concentrations in unhealthy populations.
including the introduction of FA supplementation and the 
monitoring of women’s health conditions, with the purpose 
of ensuring adequate folate blood concentrations prior to 
pregnancy.
One of the purposes of this review was to assess the 
impact of the FA fortification of wheat flour and cornmeal 
on serum and on red blood cell folate concentrations by 
comparing the pre- and post-fortification periods in Brazil. 
The analysis shows that most of the studies were carried 
out in the southeastern geographical region of the country; 
and there is a relative scarcity of studies covering the other 
regions, especially the mid-west and the northern areas; 
thus, the results presented herein cannot be considered to be 
representative of the country as a whole.
In healthy populations, an increase in serum folate 
concentrations was observed (57% in children and adolescents 
and 174% in adults). The observation that serum folate 
concentrations increased since fortification is a common 
characteristic with similar studies carried out with North 
American56,57  and Chilean58  populations. It is important to 
emphasize that the difference in blood folate concentrations 
between the pre- and post-fortification periods in Brazil may 
be greater than that observed in this review, since few studies 
that involved blood draws in the last three to four years were 
encountered.
Although this review presents folate concentrations (serum 
and red blood cell) among pregnant women and the elderly, it 
was not possible to make a comparison between the pre- and 
post-fortification values for pregnant women, due to the small 
number of post-fortification studies involving this cohort, but 
also because of the diversity of the gestational ages of pregnant 
women presented in these studies. It is known that there 
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Pregnant women Pregnant women
Guerra-
Shinohara, 
Paiva et al., 
200211
August to 
November 
1999
Jundiaí -  
SP
Women in 
labor (38 to 42 
weeks)
51 689 (± 311)a Ionic 
capture (IMx 
System®. 
ABBOTT)
Guerra-
Shinohara, 
Pereira et al., 
201013
February 
2004 to 
December 
2005
São Paulo 
- SP
Healthy 
pregnant 
women
82 1213 (917; 
1396)d
CL (Immulite®, 
DPC Med Lab)
Guerra-
Shinohara, 
Morita et al., 
20047
2001 Sorocaba -  
SP
Women in 
labor (38 to 42 
weeks)
116 643 (591 - 
701)b
Ionic 
capture (IMx 
System®. 
ABBOTT)
Neonates Neonates
Guerra-
Shinohara, 
Paiva et al., 
200211
August to 
November 
1999
Jundiaí -  
SP
Blood sample 
from umbilical 
cord
48 1075 (± 
400)a
Ionic 
capture (IMx 
System®. 
ABBOTT)
Guerra-
Shinohara, 
Morita et al., 
20047
2001 Sorocaba -  
SP
Blood sample 
from placental 
neonatal vein
116 1108 (1033 
– 1188)b
Ionic 
capture (IMx 
System®. 
ABBOTT)
Adolescents Adolescents
Do Prado, 
D’almeida et 
al., 200617
November 
2002 to 
September 
2003
São Paulo –  
SP
Healthy 
children and 
adolescents (29 
girls)
32 599 (± 246)a Ionic 
capture (IMx 
System®. 
ABBOTT)
Almeida Dantas 
e De Arruda, 
201055
2007 to 2008 Recife - PE Adolescents 
(girls)
25 1664 (± 213)a ECL (Elecsys®)
Adults Adults
Barbosa, 
Stabler, 
Trentin et al., 
200837
2003 Sorocaba -  
SP
Healthy 
women
102 892 (807 - 
987)b
CL 
(Immulite®, 
DPC Med 
Lab)
Almeida Dantas 
e De Arruda, 
201055
2007 to 2008 Recife - PE Healthy 
women
335 1809 (± 364)a ECL (Elecsys®)
CL: chemiluminescence; ECL: electrochemiluminescence. 
a Red blood cell folate concentration: mean (± SD). 
b Red blood cell folate concentration: geometric means (95% CI). 
c Red blood cell folate concentration: median. 
d Red blood cell folate concentration: median (P25-P75).
Table 6 - Red blood cell folate concentrations in healthy pregnant women, neonates, adolescents and adults.
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NTD and abortion NTD and abortion
Cunha, Hirata 
et al., 200248
? São Paulo 
- SP
Children 
with NTD, 
polymorphism 
MTHFR C677T
CC
CT/TT
12
13
760 (± 260)a
720 (± 180)a
Ionic 
capture (IMx 
System®. 
ABBOTT)
Guerra-
Shinohara, 
Pereira et al., 
201013
February 
2004 to 
December 
2005
São Paulo -  
SP
Women 
who had 
spontaneous 
abortion
12 1145 (911; 
1392)d
CL (Immulite®, 
DPC Med Lab)
Cardiometabolic alterations Cardiometabolic alterations
Uehara e Rosa, 
200850
2002 to 2003 Rio de 
Janeiro - RJ
Adults with MS: 
- Men  
- Women
24 
39
334 (± 121)e 
378 (± 167)e
RIA 
(Dualcount)
Other conditions Other conditions
Do Prado, 
D’Almeida et 
al., 200617
November 
2002 to 
September 
2003
São Paulo –  
SP
Children and 
adolescents 
with SLE (29 
girls)
32 603 (± 281)a Ionic 
capture (IMx 
System®. 
ABBOTT)
NTD: neural tube defects; MTHFR: methylenetetrahydrofolate reductase; MS: metabolic syndrome; SLE: systemic lupus erythematosus; RIA: radioisotope assay; CL: 
chemiluminescence. 
a Red blood cell folate concentration: mean (± SD). 
b Red blood cell folate concentration: geometric means (95% CI).  
c Red blood cell folate concentration: median.  
d Red blood cell folate concentration: median (P25-P75). 
The missing information was represented with a question mark (?).
Table 7 - Red blood cell folate concentrations in unhealthy populations.
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is a reduction in blood folate from the beginning to the end 
of pregnancy14,59 and, accordingly, the comparison of values 
among different gestational ages could result in biased data. 
Among the elderly, there is a lack of studies during the pre-
fortification period; as only one study involving 8 individuals 
was found for this period, no comparison is possible.
Another point to be considered is the difference in results 
when different methods are used for the quantification of 
folate. This fact was brought to our attention in a study in 
which enzyme immunoassay and chemiluminescent methods 
were used to quantify folate concentration in pregnant 
women.10 Recently, we analyzed the serum folate content in 
108 samples using two methods: one microbiological method 
and one chemiluminescent method (Immulite® Kit, DPC Med 
Lab). The results showed that the two methods presented 
different means, with higher values of folate recorded using 
the microbiological method [median (25-75 percentiles): 34.7; 
range: 21.3-46.2 nmol/L] compared to the chemiluminescent 
method (median: 30.2; range: 19.3-37.6 nmol/L; Wilcoxon 
signed-rank test: p-value < 0.001); however, there was a 
significant correlation between the results of the two tests (r 
= 0.901; Spearman Correlation: p-value < 0.001). The different 
results obtained in the dosages of serum folate are the result 
of a lack of a specific ligand for folate or anti-folate monoclonal 
antibodies that could be used in the enzyme immunoassay or 
chemiluminescence kits.
Accordingly, if we consider the differences (14.5%) between 
the two methods (microbiological and chemiluminescent), 
this difference is much smaller than the difference found 
between the post- and pre-fortification periods in the groups 
of children and adolescents (57%) and adults (174%), leaving 
no doubt that there has been an increase in the concentration 
of serum folate since mandatory fortification.
In this review, it was not possible to evaluate the difference of 
red blood cell folate concentrations between the pre- and post-
fortification periods, because different kits were used in the 
studies that evaluated similar population groups. It has already 
been described in the literature that different quantification 
methods may generate different results for red blood cell 
folate concentration.60,61 It is known that TT genotype carriers 
of the MTHFR  c.677C>T polymorphism present elevated red 
blood cell folate values compared to CC and CT genotype 
carriers, when folate is quantified by means of methods that 
use milk proteins as folate ligands (enzyme immunoassay or 
chemiluminescence and radio assay). However, TT genotype 
carriers present lower red blood cell folate values compared 
to other genotypes if the microbiological method is used. One 
possible explanation for this finding is that individuals with 
the TT genotype may accumulate formylated forms of folate 
or degradation products due to the decreased activity of the 
MTHFR enzyme, so that these forms may be quantified by 
methods that use milk proteins as ligands, rather than being 
quantified by the microbiological method, as they are not 
active forms of folate.61 
Regarding the impact of FA fortification of flour on the rate 
of NTDs, several countries that have adopted the program 
have demonstrated a reduction in the occurrence of NTDs. In 
Latin America, a 33% to 59% reduction in the occurrence of 
NTDs has been observed.62 Furthermore, a collaborative study 
conducted in Chile, Argentina and Brazil observed that the 
incidence of anencephaly and spina bifida per 1000 births in 
Brazil alone dropped from 1.12 to 0.69 and from 1.45 to 1.42, 
respectively.63 
In Brazil, one study found no significant differences 
between the incidence of anencephaly, encephalocele and 
spina bifida between the two periods;64 another study found a 
significant reduction (39%) in the incidence of spina bifida.65 
Recently a transversal study has shown that the incidences 
of anencephaly and spina bifida were reduced by 22% and 
48%, respectively, with no reduction in the incidence of 
encephalocele in municipals of the state of São Paulo following 
mandatory fortification. In total, the incidence of NTDs has 
dropped 35%, from 0.57 to 0.37 cases per 1000 live births.66 
Besides these studies, a systematic review in nine countries 
(Brazil, Chile, Argentina, Canada, the USA, Costa Rica, Iran, 
Jordan and South Africa) observed that the FA fortification of 
foods has had a considerable impact, with reductions in the 
incidence of NTDs varying between 15.5% and 58.0%.67 
Another way of evaluating the impact of fortification 
is by means of dietary folate intake, such that a significant 
decline in the rate of inadequate folate intake has been 
observed in the countries that have adopted mandatory FA 
fortification.68-70 In Brazil, transversal studies have shown 
inadequate folate intake among pregnant women,71-73 
teenagers74  and adults75  in the pre-fortification period. 
However, in the post-fortification period, no inadequate folate 
intake has been observed among pre-school children.76 An 
inadequate intake of FA was observed in 15.2% adolescents in 
the town of Indaiatuba (state of São Paulo).21 
Finally, one factor that must be taken into consideration 
when evaluating the FA fortification of flour is the level of 
compliance with legislation by flour mills. ANVISA RDC 
Resolution no. 344 mandates the addition of 150 μg of FA to 
every 100 g of wheat flour and cornmeal; however, a maximum 
limit for the quantity of FA has not been established. Non-
compliant FA concentrations regarding RDC no. 344 have 
been observed in cornmeal (from 96 to 558 μg per 100 g) 
and in wheat flour (73 to 233 μg per 100 g).77 Since both lack 
and excess of folate can be harmful, these data emphasize 
the need for constant monitoring of the FA content in 
flour products by health authorities, especially as several 
studies have observed supraphysiological concentrations 
of this vitamin (serum folate > 45 nmol/L) among several 
populations. In conclusion, the studies show an increase in 
the serum concentrations of folate and a reduction in the 
incidence of NTDs in Brazil. However, national wide-range 
evaluations are necessary, in order to be able to monitor 
blood concentrations in the Brazilian population and the FA 
content of fortified foods.
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